EURORDIS-Rare Diseases Europe’s Post

As the #OpenAcademy2024 participants join our community of alumni, we are taking a look back at this year’s trainings! Taking place in June, we welcomed 70+ advocates from 23 countries, along with over 25 faculty, to Barcelona for the intensive in-person training of our Medicines Research and Development School and Scientific Innovation & Translational Research School. 🗣️ The best part? “Engaging with the other participants in a very tangible way. Also, to hear and learn about their various ‘roadmaps’ and stories. Very humbled and inspired. And of course, the actual learnings! I really feel I have learnt a lot which I will be able to apply in my patient advocacy work.” - EURORDIS Open Academy Participant 👉 https://lnkd.in/ey_Q7mVY #EURORDISOpenAcademy #RareDiseases #Europe #training #CapacityBuilding #PatientAdvocacy

Claas Röhl

Gründer und Obmann NF Kinder Gründer und Obmann EUPATI Austria Gründer und Vize-Obmann Allianz der österreichischen PatientInnenorganisationen Vorstandsmitglied bei Pro Rare Austria

2mo

The EURORDIS training on orphan drug development was the first educational program of my patient advocacy journey back in 2015. I learnt a lot and would reommens it to everyone who wants to get involved in R&D.

Mary Lynne Van Poelgeest-Pomfret

President World Federation of Incontinence and Pelvic Problems. WFIPP

2mo

It was a truly inspiring experience both in terms of new knowledge learnings and meeting wonderful people

fereshteh hadipour

Clinical Genetics, rare & Genetic disease, Diagnosis & Managment -Fertility & Infertility Research and Clinic

2mo

Keep growing!

Carolina Lapostol Matta

Coordinadora Ensayos Clinicos / Clinical Trial Manager

2mo

Inspiring!

See more comments

To view or add a comment, sign in

Explore topics